Cargando…

Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models

OBJECTIVE: To conduct a systematic review of economic models of newer anticoagulants for stroke prevention in atrial fibrillation (SPAF). PATIENTS AND METHODS: We searched Medline, Embase, NHSEED and HTA databases and the Tuft’s Registry from January 1, 2008 through October 10, 2012 to identify econ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limone, Brendan L., Baker, William L., Kluger, Jeffrey, Coleman, Craig I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633898/ https://www.ncbi.nlm.nih.gov/pubmed/23626785 http://dx.doi.org/10.1371/journal.pone.0062183

Ejemplares similares

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
por: Lee, Soyon, et al.
Publicado: (2012)

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
por: López-López, José A, et al.
Publicado: (2017)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Publicado: (2018)

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis
por: Baczek, Victoria L, et al.
Publicado: (2012)

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient
por: Yates, Scott W
Publicado: (2013)

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
por: Morais, João, et al.
Publicado: (2016)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
por: Verhoef, Talitha I., et al.
Publicado: (2014)

Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in Low and Middle-Income Countries: A Systematic Review
por: Souresrafil, Aghdas, et al.
Publicado: (2022)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
por: Barnes, Geoffrey D., et al.
Publicado: (2022)

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival
por: Tiosano, Shmuel, et al.
Publicado: (2023)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
por: Deitelzweig, Steve, et al.
Publicado: (2013)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest Treatment
por: Diener, Hans-Christoph
Publicado: (2014)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
por: Ansell, Jack
Publicado: (2017)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
por: Lotufo, Paulo Andrade
Publicado: (2018)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis
por: Thom, Howard H. Z., et al.
Publicado: (2019)

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
por: Bowrin, Kevin, et al.
Publicado: (2020)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
por: O'Neal, Wesley T., et al.
Publicado: (2018)

Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review
por: Patel, Nirav, et al.
Publicado: (2018)

Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study
por: Azahar, Siti Norain, et al.
Publicado: (2022)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
por: Dobesh, Paul P., et al.
Publicado: (2015)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1isvfvkj5kb99m9mk3i6sbi9pf